Fresenius Kabi expands production site in Portugal
July 6, 2017
Fresenius Kabi has put two new production lines for antibiotics into operation at its plant in Santiago de Besteiros, Portugal. Representing the national government at the opening ceremony were special guests Manuel Delgado, Secretary of State of Health, and João Vasconcelos, Secretary of State of Industry.
A new 6,000-square-meter (almost 65,000-square-foot) building was erected to house the two lines, which will be used to produce penicillin for intravenous administration. About 80 new jobs are being created at the Santiago de Besteiros plant by the expansion. The total investment is about €17 million.
Dr. Michael Schönhofen, member of the Fresenius Kabi Management Board and President of the Pharmaceuticals Division, said: “This expansion is a clear commitment to our Santiago de Besteiros facility, and to Portugal. It is also a part of fulfilling our promise to provide patients worldwide with high-quality drugs.”
The Fresenius Kabi plant in Santiago de Besteiros manufactures various pharmaceuticals, such as antibiotics and infusion solutions. As one of Portugal’s largest pharmaceutical production sites, it has about 600 employees.
Representing the national government at the opening ceremony: Secretaries of State Manuel Delgado (fifth from right) and João Vasconcelos (fifth from left) with further political representatives and Fresenius Kabi employees.